SHS stands for life science and medical technology investments.

For more than 25 years.

Our investment focus

From young companies to medium-sized businesses: We invest in fast-growing companies in the life science and medical technology sector.

Our portfolio

From cardiology to digital health: Our portfolio currently comprises more than 20 companies from the various life science and medical technology sub sectors.

Our investors

From pension funds to family offices: For many years partners have entrusted us with their capital in order to achieve attractive returns on it.

We are one of the leading life science & medical technology growth investors in Germany

SHS

Experience for more
than 25 years

Since its foundation in 1993, SHS has been involved in innovative companies in the fields of life science and medical technology.

We invest in young companies and also in established medium-sized companies.

Based on our long-standing sector experience, we contribute to partnerships not only our contacts with leading doctors, health insurance companies and industry experts, but also specialist expertise and an eye for long-term value-creating measures.

SHS in figures

0

Years of history

0

Fund generations

0

Transactions

0

Million €
current fund volume

0

Million €
AUM
(ca.)

0

Transactions assessments p.a.
(ca.)

Latest News

14 October 2020 - SHS News

Prof. Dr. med. Marc O. Schurr, founder of Ovesco, appointed Senior Advisor to Tübingen-based SHS

22 September 2020 - SHS News

SHS invests in Salvia BioElectronics B.V.

2 September 2020 - Portfolio News

Miracor Medical raises 24M€